113 related articles for article (PubMed ID: 35736434)
1. Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation.
Starodubtseva NL; Chagovets VV; Nekrasova ME; Nazarova NM; Tokareva AO; Bourmenskaya OV; Attoeva DI; Kukaev EN; Trofimov DY; Frankevich VE; Sukhikh GT
Metabolites; 2022 May; 12(6):. PubMed ID: 35736434
[TBL] [Abstract][Full Text] [Related]
2. Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation.
Starodubtseva NL; Brzhozovskiy AG; Bugrova AE; Kononikhin AS; Indeykina MI; Gusakov KI; Chagovets VV; Nazarova NM; Frankevich VE; Sukhikh GT; Nikolaev EN
J Mass Spectrom; 2019 Aug; 54(8):693-703. PubMed ID: 31116903
[TBL] [Abstract][Full Text] [Related]
3. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia.
Wu J; Li X; Liu X; Gao Z
Int J Clin Exp Pathol; 2018; 11(9):4614-4621. PubMed ID: 31949860
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
6. [The Clinical Significance of HPV L1/PD-L1 Tests Combined with Colposcopy for Cervical Precancerous Lesions and Cervical Cancer].
Luo GP; Zeng X; Cao HY; Tang D; Xi MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):516-522. PubMed ID: 34018374
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
Paluszkiewicz A; Pruski D; Iwaniec K; Kędzia W
Ginekol Pol; 2017; 88(3):141-146. PubMed ID: 28397203
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
9. Feature selection for OPLS discriminant analysis of cancer tissue lipidomics data.
Tokareva AO; Chagovets VV; Starodubtseva NL; Nazarova NM; Nekrasova ME; Kononikhin AS; Frankevich VE; Nikolaev EN; Sukhikh GT
J Mass Spectrom; 2020 Jan; 55(1):e4457. PubMed ID: 31661719
[TBL] [Abstract][Full Text] [Related]
10. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
Liu J; Yang T; Hu Y; Ye C
J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
[TBL] [Abstract][Full Text] [Related]
11. Correlation of P16 (Ink4a) and CK17 to HPV (16E6+18E6) in Premalignant and Malignant Lesions of Uterine Cervix: A Clinicopathologic Study.
Chaloob MK; Hussein AG; Qasim BJ
Iran J Pathol; 2016; 11(4):377-390. PubMed ID: 28855930
[TBL] [Abstract][Full Text] [Related]
12. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
[TBL] [Abstract][Full Text] [Related]
13. HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico.
DelaRosa-Martínez R; Sánchez-Garza M; López-Revilla R
Infect Agent Cancer; 2016; 11():16. PubMed ID: 27030798
[TBL] [Abstract][Full Text] [Related]
14. "Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions".
Grapsa D; Frangou-Plemenou M; Kondi-Pafiti A; Stergiou E; Nicolopoulou-Stamati P; Patsouris E; Chelidonis G; Athanassiadou P
Diagn Cytopathol; 2014 Jun; 42(6):465-75. PubMed ID: 23729286
[TBL] [Abstract][Full Text] [Related]
15. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
Ding Z; Li Y; Chen A; Song M; Zhang Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
17. Non-Invasive Differential Diagnosis of Cervical Neoplastic Lesions by the Lipid Profile Analysis of Cervical Scrapings.
Tokareva A; Chagovets V; Attoeva D; Starodubtseva N; Nazarova N; Gusakov K; Kukaev E; Frankevich V; Sukhikh G
Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144287
[TBL] [Abstract][Full Text] [Related]
18. CHAPTER 3 Pathology of HPV infection at the cytologic and histologic levels: Basis for a 2-tiered morphologic classification system.
Wright TC
Int J Gynaecol Obstet; 2006 Nov; 94 Suppl 1():S22-S31. PubMed ID: 29644630
[TBL] [Abstract][Full Text] [Related]
19. A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
Hong SA; Yoo SH; Choi J; Robboy SJ; Kim KR
Arch Pathol Lab Med; 2018 Aug; 142(8):973-981. PubMed ID: 29652189
[TBL] [Abstract][Full Text] [Related]
20. AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix.
Srivastava AN; Misra JS; Singh U; Khan M; Raza S
Acta Cytol; 2019; 63(5):371-378. PubMed ID: 31067531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
